Marqeta, Inc. (NASDAQ:MQ) has been identified as one of the most promising small-cap stocks by Wall Street analysts, positioning it prominently in the financial technology sector. Despite this positive outlook, the company faced a cautious assessment from Morgan Stanley, which, on February 25, reportedly lowered its price target for MQ from $6 to $5, while maintaining an 'Equal Weight' rating. This adjustment reflects the firm's view of Marqeta as a 'show-me' story, primarily due to concerns over the consistency of its financial performance, which continues to be a key factor for investor confidence.
The company released its comprehensive financial results for the fourth quarter and the full year of 2025 on February 24, highlighting significant operational achievements. In the fourth quarter, Marqeta reported a net revenue of $172 million and a gross profit of $120 million, marking increases of 27% and 22%, respectively. The total processing volume for Q4 surged by 36% year-over-year, reaching $109 billion. Furthermore, the adjusted EBITDA rose to $31 million, and the GAAP net loss substantially narrowed to just $1 million, indicating improved profitability and operational efficiency.
For the entire fiscal year 2025, Marqeta's processing volume grew by 31% to $383 billion. Net revenue climbed to $625 million, a 23% increase, and gross profit expanded by 24% to $437 million, with a robust gross margin of 70%. The adjusted EBITDA for the full year stood at $110 million, with the GAAP net loss reducing to $14 million. These results underscore a period of strong growth in transaction volumes, enhanced profitability, and greater efficiency in operations. These foundational improvements are expected to drive increased consumer engagement and market expansion in the coming year, laying a solid groundwork for continued progress.
Marqeta, Inc. stands as a testament to the dynamic potential within the fintech industry, demonstrating that even amidst critical analyst evaluations, strategic operational enhancements and consistent growth can forge a path toward sustained success and broader market influence. The company's focus on innovation and efficiency reflects a forward-looking approach, promising an engaging future for its stakeholders and the evolving financial landscape.